Dr. Paul R. Kaesberg, MD

Dr. Kaesberg practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Kaesberg's NPI, 1023084035, was assigned on February 28, 2006. Dr. Kaesberg graduated from University of Wisconsin School of Medicine in 1982. Dr. Kaesberg holds California license G88099.

Dr. Kaesberg's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Kaesberg's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Kaesberg is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Kaesberg to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaesberg practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kaesberg's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Kaesberg's licenses on file in 2 states: California and Wisconsin.

CMS data shows 1,283 Medicare services from Dr. Kaesberg across 9 procedure codes in 2024, for 426 Medicare patients. Medicare paid $68,531 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 426 Medicare patients who saw Dr. Kaesberg in 2024. The largest group is 65 to 74, with 176 patients. 73% of them have high blood pressure, and 72% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaesberg's median patient age at 69, with 49% women.

In 2024, Dr. Kaesberg wrote 608 Medicare Part D claims for 110 patients. 62% of them were for generic drugs. CMS names the drug for 380 of them, across 15 drugs with 11 or more claims each, at $2,493,333 in total drug cost. In 2023, CMS named 457 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kaesberg for performance year 2024, reported as part of a group. Dr. Kaesberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaesberg as offering telehealth.

Dmand AI links 9 papers to Dr. Kaesberg, published from 2013 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Kaesberg's most frequent co-authors are Brian Andrew Jonas, MD, PhD, Aaron S. Rosenberg, MD, MS and Joseph M. Tuscano, MD.

CMS Open Payments shows 285 general payments to Dr. Kaesberg from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 85% of the total. Incyte Corporation paid the most, $100,851.

Dr. Kaesberg graduated from University of Wisconsin School of Medicine in 1982.